Characteristics and clinical outcomes of breast cancer in young BRCA carriers according to tumor histology
E Agostinetto,M Bruzzone,A-S Hamy,H J Kim,C Chiodi,R Bernstein-Molho,S Linn,K Pogoda,E Carrasco,F Derouane,J Bajpai,G Nader-Marta,N Lopetegui-Lia,A H Partridge,L Cortesi,C Rousset-Jablonski,F Giugliano,T Renaud,A Ferrari,S Paluch-Shimon,R Fruscio,W Cui,S M Wong,C Vernieri,K J Ruddy,M V Dieci,A Matikas,M Rozenblit,D Aguilar Y Mendez,L De Marchis,R Borea,F Puglisi,M Pistelli,J Kufel-Grabowska,R Di Rocco,E Mariamidze,F Atzori,H R Kourie,L Popovic,E de Azambuja,E Blondeaux,M Lambertini
DOI: https://doi.org/10.1016/j.esmoop.2024.103714
IF: 6.883
ESMO Open
Abstract:Background: Young women with breast cancer (BC) have an increased chance of carrying germline BRCA pathogenic variants (PVs). Limited data exist on the prognostic impact of tumor histology (i.e. ductal versus lobular) in hereditary breast cancer. Methods: This multicenter retrospective cohort study included women aged ≤40 years with early-stage breast cancer diagnosed between January 2000 and December 2020 and known to carry germline PVs in BRCA1/2. Histology was locally assessed in each center. The Kaplan-Meier method and Cox regression analysis were used to assess disease-free survival and overall survival. Results: Of 4628 patients included from 78 centers worldwide, 3969 (86%) had pure ductal, 135 (3%) pure lobular, and 524 (11%) other histologies. Compared with ductal tumors, lobular tumors were more often grade 1/2 (57.7% versus 22.1%), stage III (29.6% versus 18.5%), and luminal A-like (42.2% versus 12.2%). Lobular tumors were more often associated with BRCA2 PVs (71.1% BRCA2), while ductal tumors were more often associated with BRCA1 PVs (65.7% BRCA1). Patients with lobular tumors more often had mastectomy (68.9% versus 58.3%), and less often received chemotherapy (83.7% versus 92.9%). With a median follow-up of 7.8 years, no significant differences were observed in disease-free survival (adjusted hazard ratio 1.01, 95% confidence interval 0.74-1.37) or overall survival (hazard ratio 0.96, 95% confidence interval 0.62-1.50) between patients with ductal versus lobular tumors. No significant survival differences were observed according to specific BRCA gene, breast cancer subtype, or body mass index. Conclusions: In this large global cohort of young BRCA carriers with breast cancer, the incidence of pure lobular histology was low and associated with higher disease stage at diagnosis, luminal-like disease and BRCA2 PVs. Histology did not appear to impact prognosis.